Table 5 Comparison between COVID-19 positive and negative patients with co-infections.

From: Incidence of common respiratory pathogens among patients with severe acute respiratory infection during COVID-19 pandemic in Egypt

 

POS COVID − 19 with coinfection

(n = 120)

NEG COVID-19 with infections

(n = 330)

P-value

Gender

0.853

 Male

57 (47.5)

160 (48.5)

 

 Female

63 (52.5)

170 (51.5)

 

Age group (years)

< 0.001

 Less than 15 years

8 (6.7)

108 (32.7)

 

 15-

29 (24.2)

91 (27.6)

 

 40-

42 (35)

68 (20.6)

 

 ≥ 60

41 (34.2)

63 (19.1)

 

Comorbidities

 Hypertension

29 (24.2)

45 (13.6)

0.008

 Diabetes

24 (20)

39 (11.8)

0.027

 Chronic cardiac disease

15 (12.5)

54 (16.4)

0.314

 Chronic respiratory disease

10 ( 8.3)

34 (10.3)

0.534

 Obesity

6 (5)

15 (4.5)

0.84

Symptoms

 Fever

81 (67.5)

217 (65.8)

0.730

 Cough

100 (83.3)

275 (83.3)

1

 Dyspnea

81 (67.5)

230 (69.7)

0.656

 Diarrhea

35 (29.2)

103 (31.2)

0.677

 Loss of smell

34 (28.3)

69 (20.9)

0.097

 Loss of taste

34 (28.3)

62 (18.8)

0.029

 Running nose

40 (33.3)

149 (45.2)

0.025

 Sore throat

51 (42.5)

131 (39.7)

0.592

 Vascular event

10 (8.3)

35 (10.6)

0.477

Severity

 Mild

42 (19.8)

170 (51.5)

0.008

 Moderate

52 (32.3)

109 (33)

 

 Severe

26 (33.8)

51 (15.5)

 

Healthcare type

 Home isolation

29 (24)

80 (24.2)

0.022

 Hospital intermediate care

15 (12.5)

25 (7.5%)

 

 Hospital ward

45 (37.5)

165 (50)

 

 ICU admission

20 (16.6)

27 (8.2)

 

 Mortality

14 (11.7)

12 (3.6)

0.001

Laboratory tests (Median (IQR))

 TLC

7.62 (3.71)

8 (4.48)

0.921

 Absolute neutrophilic count

4.84 (3.52)

4.8 (3.37)

0.226

 Absolute lymphocytic count

1.31 (2.1)

1.9 ( 2.2)

0.037

 Neutr/Lymph ratio

3.3 (4.78)

2.42 (2.95)

0.005

 Absolute monocytic count

0.61 (0.6)

0.6 (0.57)

0.698

 Platelet

223 (104)

275 (150)

< 0.001

 Ferritin

1.14 (2.47)

0.98 (1.59)

0.127

 D- dimer

23 (19)

19 (14)

0.022

 ALT

23 (19)

20 (17)

0.068

 CRP

375 (578)

217 (290)

0.003